<DOC>
	<DOC>NCT02079168</DOC>
	<brief_summary>To evaluate the effectiveness of RXI-109 in reducing the recurrence of keloid formation following elective keloid excision.</brief_summary>
	<brief_title>A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Keloid</mesh_term>
	<criteria>Adults, 2155 years of age. Two keloids of approximately similar size and anatomical location on the earlobe, neck, or torso. Keloids to be excised must have been present for &gt; 1 year. Use of tobacco or nicotinecontaining products Pregnant or lactating Postmenopausal or full hysterectomy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Keloid</keyword>
	<keyword>Cicatrix</keyword>
	<keyword>Keloid prevention</keyword>
	<keyword>Keloid revision/excision</keyword>
	<keyword>Keloidectomy</keyword>
</DOC>